Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nelson

Showing results (261-270 of 316) with videos related to

Pageof 32
Sort By:
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|June 30, 2026
Rural cancer research activity across Europe: A bibliometric analysis on patterns, gaps and policy implicationsTanja K Kleinhappel, Natalia Calanzani, Samuel Cooke, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 4, 2015
Generating and evaluating evidence of the clinical utility of molecular diagnostic tests in oncologyPatricia Deverka, Donna A Messner, Robert McCormack, et al.
Neurogenetics|August 15, 2012
Small genomic rearrangements involving FMR1 support the importance of its gene dosage for normal neurocognitive functionSandesh C S Nagamani, Ayelet Erez, Frank J Probst, et al.
European Journal of Gastroenterology & Hepatology|June 6, 2014
VX-222, a non-nucleoside NS5B polymerase inhibitor, in telaprevir-based regimens for genotype 1 hepatitis C virus infectionAdrian M Di Bisceglie, Mark Sulkowski, Ed Gane, et al.
Hepatology (Baltimore, Md.)|June 24, 2008
R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirinPaul J Pockros, David Nelson, Eliot Godofsky, et al.
Hepatology (Baltimore, Md.)|February 28, 2007
Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosisPaul J Pockros, Lennox Jeffers, Nezam Afdhal, et al.
Therapeutic Drug Monitoring|July 3, 2009
Pediatric acute lymphoblastic leukemia and exposure to pesticidesOffie P Soldin, Hala Nsouli-Maktabi, Hala Nsouly-Maktabi, et al.
Antiviral Therapy|February 8, 2014
Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitorDavid Nelson, Eric M Yoshida, Matthew S Paulson, et al.
Clinical Transplantation|January 11, 2023
A survey of intensive care unit models in cardiothoracic transplantation at high-volume centersMichael Nurok, Mark E Nunnally, George Gill, et al.
The Annals of Thoracic Surgery|February 21, 2023
Surgical Approach and Persistent Opioid Use in Medicare Patients Undergoing Lung Cancer ResectionNicolas Zhou, Jiangong Niu, David Nelson, et al.
Pageof 32

Showing results (261-270 of 316) with videos related to

Sort By:
Pageof 32
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|June 30, 2026
Rural cancer research activity across Europe: A bibliometric analysis on patterns, gaps and policy implicationsTanja K Kleinhappel, Natalia Calanzani, Samuel Cooke, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 4, 2015
Generating and evaluating evidence of the clinical utility of molecular diagnostic tests in oncologyPatricia Deverka, Donna A Messner, Robert McCormack, et al.
Neurogenetics|August 15, 2012
Small genomic rearrangements involving FMR1 support the importance of its gene dosage for normal neurocognitive functionSandesh C S Nagamani, Ayelet Erez, Frank J Probst, et al.
European Journal of Gastroenterology & Hepatology|June 6, 2014
VX-222, a non-nucleoside NS5B polymerase inhibitor, in telaprevir-based regimens for genotype 1 hepatitis C virus infectionAdrian M Di Bisceglie, Mark Sulkowski, Ed Gane, et al.
Hepatology (Baltimore, Md.)|June 24, 2008
R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirinPaul J Pockros, David Nelson, Eliot Godofsky, et al.
Hepatology (Baltimore, Md.)|February 28, 2007
Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosisPaul J Pockros, Lennox Jeffers, Nezam Afdhal, et al.
Therapeutic Drug Monitoring|July 3, 2009
Pediatric acute lymphoblastic leukemia and exposure to pesticidesOffie P Soldin, Hala Nsouli-Maktabi, Hala Nsouly-Maktabi, et al.
Antiviral Therapy|February 8, 2014
Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitorDavid Nelson, Eric M Yoshida, Matthew S Paulson, et al.
Clinical Transplantation|January 11, 2023
A survey of intensive care unit models in cardiothoracic transplantation at high-volume centersMichael Nurok, Mark E Nunnally, George Gill, et al.
The Annals of Thoracic Surgery|February 21, 2023
Surgical Approach and Persistent Opioid Use in Medicare Patients Undergoing Lung Cancer ResectionNicolas Zhou, Jiangong Niu, David Nelson, et al.
Pageof 32